Abstract:Abstract Background: Habb-E-Shifa , Hamdard Sualin , and Hamdard Joshanda traditional herbal medicines may promote host resistance against infection by bacteria, viruses, and fungi which are easily accessible at inexpensive with no complexity. These herbal medicines are used to cure sore throat, cough, fever, lung cancer, and asthma patients in developing South Asian countries. These traditional herbal medicines acted a crucial role in the prevention and control of coronavirus disease 2019 (COVID-19). Aims and Objectives: This research article aimed at conducting phytochemistry, antimicrobial activity, COVID-19 docking and some spectroscopic (Infrared, Ultraviolet, 13 C-Nuclear Magnetic Resonance ( 13 C-NMR), 1 H-NMR, and Mass Spectra) characterizations of the polyherbal drugs were carried out. Additionally, In-vitro and In-silico analyses were performed to measure activity against COVID-19. High Performance - Liquid Chromatography (HPLC), Gas Chromatography - Mass Spectrometry (GC-MS), antimicrobial, and docking studies were carried out. The preliminary phytochemical assay and bioactive compounds were screened using HPLC and GC-MS. The study is an attempt to assess the promising effects of selected polyherbal indigenous drugs such as Habb-E-Shifa , Hamdard Sualin , and Hamdard Joshanda phytoconstituents against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Materials and Methods: The extract of the selected polyherbal formulations showed high-to-moderate preventive effects on the growth inhibition in the pathogenic bacterium, namely Streptococcus oralis , Staphylococcus aureus , Propionibacterium acnes , Pseudomonas aeruginosa , Escherichia coli , and Proteus vulgaris , and three fungal Candida albicans, Aspergillus fumigatus , and Aspergillus niger . Further docking study evaluates the pharmacological activity of bioactive chemical compounds with SARS-CoV-2 NSP5 (PDB ID: 7nxh) and SARS-CoV-2 Omicron spike protein with human angiotensin-converting enzyme 2 (ACE-2) (PDB ID: 7wk6). Results: In this study, for the first time, we attempted to examine some spectroscopic characterization of selected herbals. The total phenol content (1.66, 1.55, and 1.13 mg/mL) and total flavonoid content (4.92, 0.49, and 0.50 mg/mL) were present in the extracted samples of Habb-E-Shifa ( H ), Hamdard Joshanda ( J ), and Hamdard Sualin ( S ). Studies on COVID-19 docking infer the affinity of the herb’s chemical components toward COVID-19 protease and ACE-2 receptor by establishing excellent binding capacity in complex formation. The results confirmed that polyherbal drugs harbor biological activities and thereby highlight that these extracts can serve as a remedy for antimicrobial and COVID-19. Conclusions: The research article confirms the remarkable potential in exhibiting antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. These herbal medicines such as Habb-E-Shifa (H) , Hamdard Joshanda (J) , and Hamdard Sualin ( S ) showed a vital role against SARS-CoV-2 Omicron spike protein with human ACE2 (7wk6) and amino acids of SARS-CoV-2 NSP5 (7nxh). Our study provides obvious evidence supporting dietary therapy and herbal medicine as potentially effective against SARS-CoV-2. Based on present studies, these herbal products can be introduced as preventive and therapeutic agents fight against coronavirus.

Immune boosting and anti-influenza effects of an Unani decoction in influenza like illness and COVID-19 like epidemics: a rationale approach

TIRYAQ-E-ARBA (A POLY HERBAL UNANI FORMULATION) IN FIGHTING AGAINST COVID 19 LIKE CONDITIONS – UNANI PERSPECTIVE

Exploring new horizons in health care: A mechanistic review on the potential of Unani medicines in combating epidemics of infectious diseases

Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research

Ayurveda botanicals in COVID-19 management: An in silico multi-target approach

Phytoconstituents Profiling of Indigenous Herbal Drugs and Its in vitro Microbial, in Silico Biological Examination against Severe Acute Respiratory Syndrome Coronavirus 2

Plant resources for immunonutrients and immunomodulators to combat infectious respiratory viral diseases: a review

Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management

The Sequelae of Sleeping Issues and their Management in Post COVID-19: A Unani and Contemporary Narrative Review

Impact of nutraceuticals on immunomodulation against viral infections—A review during COVID‐19 pandemic in Indian scenario

Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics

A Systematic Review of COPD from the Perspectives of Greco-Arabic and Modern Medicine

Traditional Formulations for Managing COVID-19: A Systematic Review

Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine

Indian Herb-Derived Phytoconstituent-Based Antiviral, Antimicrobial and Antifungal Formulation: An Oral Rinse Candidate for Oral Hygiene and the Potential Prevention of COVID-19 Outbreaks

Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm

Withania Somnifera (L.) Dunal (ashwagandha) for the Possible Therapeutics and Clinical Management of SARS-CoV-2 Infection: Plant-based Drug Discovery and Targeted Therapy

Scientific appraisal of Unani concept of islah-e-advia (rectification/purification of drugs) and its importance

Prevention of Droplet and Air Born Infections w.s.r to Corona Virus Through Ayurveda –A Review

Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19

Previously published ethno-pharmacological reports reveal the potentiality of plants and plant-derived products used as traditional home remedies by Bangladeshi COVID-19 patients to combat SARS-CoV-2